Shopping Cart
- Remove All
- Your shopping cart is currently empty
CDK6/PIM1-IN-1 is a balanced, potent dual inhibitor of CDK6 (IC50: 39 nM) and PIM1 (IC50: 88 nM), also showing inhibitory activity on CDK4 (IC50: 3.6 nM). It significantly inhibits the proliferation of acute myeloid leukemia (AML) cells, arrests the cell cycle in G1 phase, induces cell apoptosis, and demonstrates anti-AML activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | CDK6/PIM1-IN-1 is a balanced, potent dual inhibitor of CDK6 (IC50: 39 nM) and PIM1 (IC50: 88 nM), also showing inhibitory activity on CDK4 (IC50: 3.6 nM). It significantly inhibits the proliferation of acute myeloid leukemia (AML) cells, arrests the cell cycle in G1 phase, induces cell apoptosis, and demonstrates anti-AML activity. |
Targets&IC50 | CDK7/Cyclin H/MNAT1:393 nM, CDK9/cyclinT1:440 nM, CDK2/cyclinA:2.274 μM, CDK3-CyclinE:>10 μM, CDK1/cyclinB:>10 μM, CDK6-CyclinD1:39 nM, PIM3:92 nM, CDK12/Cyclin K:>10 μM, Cdk5/p25:>10 μM, CDK13/Cyclin K:>10 μM, PIM2:>10 μM, Cdk4/cyclin D1:3.6 nM, PIM1:88 nM |
Molecular Weight | 473.55 |
Formula | C25H28FN9 |
Cas No. | 2677026-14-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.